Results 291 to 300 of about 1,940,572 (373)

Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b [PDF]

, 2008
Shin Yong Park, Yong Pyo Shin, Chong Han Kim, Ho Jin Park, Yeon‐Sun Seong, Byung Sam Kim, Sook Jae Seo, In Hee Lee   +7 more
openalex   +1 more source

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities. [PDF]

Front Oncol
Cai WY, Cai XX, Fei YR, Ye R, Song DM, Hu D, Zhang WW, Xia MF, Yang XX.   +8 more
europepmc   +1 more source

Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication [PDF]

, 2017
Cervantes-Barragan, Luisa, et al.,
core   +2 more sources

Reprogramming the Tumor Immune Microenvironment with ICAM‐1‐Targeted Antibody‒Drug Conjugates and B7‐H3‐CD3 Bispecific Antibodies

Advanced Science, EarlyView.
Reprogramming the tumor immune microenvironment is crucial for transforming immune “cold” tumors into “hot” inflammatory tumors. The investigation reveals that the combination of ICAM‐1‐Dxd with B7‐H3‐CD3 bispecific antibodies not only demonstrates significant inhibitory effects on tumor growth and metastasis but also plays a vital role in ...
Shoubing Zhou, Mengyu Hong, Dan Zhao, Wenyu Li, Xiaolong Yuan, Yinghong Wang, Hualong Li, Yang Yang, Tengchuan Jin, Jing Pan   +9 more
wiley   +1 more source

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance. [PDF]

Front Immunol
Shi S, Ou X, Liu C, Li R, Zheng Q, Hu L.
europepmc   +1 more source

IR783‐Stabilized Nanodrugs Enhance Anticancer Immune Response by Synergizing Oxidation Therapy and Epigenetic Modulation

Advanced Science, EarlyView.
IR783‐stabilized nanodrugs composed of NIR dye IR783, ROS inducer β‐lapachone, and epigenetic modulator CUDC101 are designed for breast cancer immunotherapy. The nanodrugs can not only promote cancer cell apoptosis through HDAC inhibition‐enhanced oxidation therapy but also reshape the immunosuppressive microenvironment, which provides a novel strategy
Jinzhao Liu, Meicen Wu, Qingyang Lyu, Chang Yang, Ni Fan, Kang Chen, Weiping Wang   +6 more
wiley   +1 more source

Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion. [PDF]

Nat Commun
Lv X, Liu J, Ruan J, Chen P, He C, Zhao X, Huang C, Chen L, Wang H, Hua G, Shi D, Yang S, Moness ML, Montoute I, Dhar A, Chen X, Kumar R, Lu H, Sadreyev R, Yeku O, Wu X, Davis JS, Wang C.   +22 more
europepmc   +1 more source

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I‐Labeled Tinurilimab

Advanced Science, EarlyView.
This study investigates the integrated diagnostic and therapeutic strategy utilizing 89Zr/131I‐labeled tinurilimab for the management of malignant lung nodules, with a particular focus on lung adenocarcinoma (LUAD). CEACAM6, which is highly expressed in most LUAD patients, activates the Src/FAK signaling pathway, thereby promoting cell proliferation ...
Chongyang Chen, Keying Zhu, Jing Wang, Donghui Pan, Xinyu Wang, Yuping Xu, Junjie Yan, Lizhen Wang, Min Yang   +8 more
wiley   +1 more source

Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma. [PDF]

Cancer Cell Int
Wen J, Wen K, Tao M, Zhou Z, He X, Wang W, Huang Z, Lin Q, Li H, Liu H, Yan Y, Xiao Z.   +11 more
europepmc   +1 more source

Non‐Membrane Active Peptide Resensitizes MRSA to β‐Lactam Antibiotics and Inhibits S. aureus Virulence

Advanced Science, EarlyView.
This work identifies a potent, non‐membrane active, and non‐toxic AMP termed GN1, which substantially resensitizes MRSA to multiple β‐lactam antibiotics at low concentrations. GN1 functions by suppressing MRSA‐associated resistance determinants, including penicillin‐binding protein 2a (PBP2a) and β‐lactamase.
Jingru Shi, Chen Chen, Pan Kong, Feiyu Yu, Qingyan Lv, Zhiqiang Wang, Yuan Liu   +6 more
wiley   +1 more source